Table 3.
0–1 Month |
1–3 Months |
3–6 Months |
After 6 Months |
Total |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Crossmatch (%) | CP | WP | N | CP | WP | N | CP | WP | N | CP | WP | N | CP | WP | N |
Primary nonfunction | 7 (9.7) | 3 (4.0) | 29 (6.4) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 (9.7) | 3(4.0) | 29 (6.4) |
Technical failure | 5(6.9) | 6(8.0) | 22 (4.9) | 1 (2.0) | 0 | 4 (1.1) | 0 | 0 | 2(0.5) | 0 | 1 (1.9) | 4 (1.2) | 6 (8.3) | 7(9.3) | 32 (7.1) |
Rejection | 6(8.3) | 1 (1.3) | 8 (1.8) | 1 (2.0) | 2 (3.2) | 3 (0.8) | 2 (4.3) | 0 | 3 (0.8) | 0 | 0 | 6 (1.8) | 9 (12.5) | 3 (4.0) | 20(4.4) |
Infection | 1 (1.4) | 1 (1.3) | 4 (0.9) | 1 (2.0) | 0 | 9 (2.4) | 0 | 3 (5.2) | 1 (0.8) | 1 (2.3) | 1 (1.9) | 2 (0.6) | 3 (4.2) | 5 (6.7) | 16 (3.5) |
Others | 4 (5.6) | 1 (1.3) | 11 (2.4) | 0 | 0 | 9 (2.4) | 1 (2.2) | 1 (1.7) | 11(3.1) | 2 (4.7) | 1 (1.9) | 10 (3.0) | 7 (9.7) | 3 (4.0) | 41 (9.1) |
Undetermined | 0 | 0 | 1 (0.2) | 0 | 0 | 0 | 0 | 1 (1.7) | 1 (0.3) | 0 | 0 | 1 (0.3) | 0 | 1 (1.3) | 3 (0.7) |
Total graft loss | 23 (31.9) | 12 (16.0) | 75 (16.6) | 3 (6.1) | 2 (3.2) | 25(6.6) | 3 (6.5) | 5 (B.6) | 18 (5.1) | 3 (7.0) | 3 (5.7) | 23 (6.9) | 32 (4) | 22 (29.3) | 141 (31.1) |
Total grafts | 72 | 75 | 453 | 49 | 63 | 378 | 46 | 58 | 353 | 43 | 53 | 335 | 72 | 75 | 453 |
Abbrivation: CP, Crossmatch positive; WP, weak positive; N. negative, P < .05: 6 (8.3) vs 8 (1.8); 9 (12.5) VS 20 (4.4).